Evidence map›Paper›PMID 38524410›Full record

ArticleACS omega2024

Hydrogen Sulfide Protects against Rat Ischemic Brain Injury by Promoting RhoA Phosphorylation at Serine 188.

Ye Chen, Shuo Chen, Miao Wu, Fang Chen, Qianjun Guan, Sen Zhang, Jiyue Wen, Zhongwu Sun, Zhiwu Chen

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Sodium hydrogen sulfide restores HInflammopharmacology · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ye ChenDepartment of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei 230000, Anhui, China.ORCID https://orcid.org/0009-0009-4310-5455
Shuo ChenDepartment of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230000, China.
Miao WuDepartment of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230000, China.
Fang ChenDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei 230000, Anhui, China.
Qianjun GuanDepartment of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230000, China.
Sen ZhangDepartment of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230000, China.
Jiyue WenDepartment of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230000, China.ORCID https://orcid.org/0000-0002-7602-1727
Zhongwu SunDepartment of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei 230000, Anhui, China.
Zhiwu ChenDepartment of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230000, China.ORCID https://orcid.org/0000-0001-9131-9030
Anhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The protective role of hydrogen sulfide against cerebral ischemia-reperfusion injury involves the inhibition of the RhoA-/Rho-associated coiled-coil kinase (ROCK) pathway. However, the specific mechanism remains elusive. This study investigates the impact of hydrogen sulfide on RhoA phosphorylation at serine 188 (Ser188) in vivo, aiming to test the hypothesis that hydrogen sulfide exerts neuroprotection by enhancing RhoA phosphorylation at Ser188, subsequently inhibiting the RhoA/ROCK pathway. Recombinant RhoA

Identifiers

PMID38524410
PMCPMC10956087
OpenAlexW4392656923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.